TERENCE WILLIAMS: Open Payments
NPI 1740807585 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 87 payments from 19 companies in 2025. Trend: 2023 $2,386 · 2024 $1,546 · 2025 $1,870
Food & beverage: $1,839Consulting: $25Travel & lodging: $6
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $524 |
| AstraZeneca Pharmaceuticals LP | 17 | $449 |
| Amgen Inc. | 15 | $174 |
| GENZYME CORPORATION | 6 | $139 |
| Insmed, Inc. | 9 | $135 |
| Philips North America LLC | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Viatris Specialty LLC | 2 | $48 |
| Grifols USA, LLC | 1 | $46 |
| Lilly USA, LLC | 2 | $39 |
Products named: NUCALA, TEZSPIRE, AIRSUPRA, FASENRA, DUPIXENT, Arikayce, TRELEGY ELLIPTA, Vest Therapy Und.
Industry payments across NC — which companies pay providers there.
